GlassScriptPhysician profile
Weldon Kent Williamson
NPI 1447238068
$954.83
in general payments reported to CMS, 2019-2025
9 companies · $49.06 in 2025
The $49.06 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $122 · 2021: $15.85 · 2022: $431 · 2023: $21.27 · 2024: $191 · 2025: $49.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $297.23 | 2022-2024 | Gore Acuseal Cardiovascular Patch Vascular |
| Medtronic, INC. | $266.04 | 2021-2024 | Endurant Iis |
| Cook Medical LLC | $125.00 | 2019 | |
| Medtronic Vascular, INC. | $121.66 | 2020 | |
| Philips North America LLC | $60.79 | 2022 | |
| Integra Lifesciences Corporation | $28.56 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $21.27 | 2023 | Ranger |
| Sanara Medtech INC. | $20.50 | 2025 | Celleraterx |
| Terumo Medical Corporation | $13.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weldon Williamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.